Amylyx Pharmaceuticals, Inc. (AMLX) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: AMLX) | Delayed: 29.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.40 | 52 Week High | $ | |||
| Open | $29.40 | 52 Week Low | $ | |||
| Day High | $29.40 | P/E | N/A | |||
| Day Low | $29.40 | EPS | $ | |||
| Volume | 1,811 | |||||
